"Science and Technology Innovation Board Breaks through the Circle of Innovation Drugs Going Global, with Potential Overseas BD Transactions Exceeding $12 Billion in the First Half of the Year."

Recently, the 2025 World Lung Cancer Congress was held in Barcelona, Spain. Innovative pharmaceutical companies on the Science and Technology Innovation Board, including BeiGene, BaiLi Tianheng, and DiZhe Pharmaceutical, all had important research selected for oral presentations at this year's conference. The overseas business development of innovative pharmaceutical companies on the Science and Technology Innovation Board has also entered a new peak. Preliminary statistics show that since 2025, these companies have completed a total of 14 authorized transactions for pipeline assets, with a potential total transaction amount exceeding 12 billion US dollars.